Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Industry, Sector and Symbol
Industry Investment offices, not elsewhere classified
Sub-IndustryN/A
SectorFinance
Phone617-772-8500
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
OptionableNot Optionable
Tekla Healthcare Investors (NYSE:HQH) Frequently Asked Questions
What is Tekla Healthcare Investors' stock symbol?
Tekla Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "HQH."
How often does Tekla Healthcare Investors pay dividends? What is the dividend yield for Tekla Healthcare Investors?
Tekla Healthcare Investors declared a quarterly dividend on Monday, November 19th. Stockholders of record on Wednesday, November 28th will be paid a dividend of $0.51 per share on Monday, December 31st. This represents a $2.04 annualized dividend and a dividend yield of 9.85%. The ex-dividend date of this dividend is Tuesday, November 27th. This is a positive change from Tekla Healthcare Investors's previous quarterly dividend of $0.47. View Tekla Healthcare Investors' Dividend History.
Has Tekla Healthcare Investors been receiving favorable news coverage?
Press coverage about HQH stock has trended positive on Saturday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Tekla Healthcare Investors earned a daily sentiment score of 2.8 on InfoTrie's scale. They also assigned media headlines about the financial services provider a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the next few days.
Who are some of Tekla Healthcare Investors' key competitors?
Some companies that are related to Tekla Healthcare Investors include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Gabelli Equity Trust (GAB), Tri-Continental (TY), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tortoise Energy Infrastructure (TYG), Royce Value Trust (RVT), Hercules Capital (HTGC), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), PIMCO High Income Fund (PHK), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF) and Solar Capital (SLRC).
Who are Tekla Healthcare Investors' key executives?
Tekla Healthcare Investors' management team includes the folowing people:
- Dr. Daniel R. Omstead M.S, Ph.D., CEO, Pres & Trustee (Age 65)
- Ms. Kimberley L. Carroll, CFO, CFO - HQL Fund, VP & Treasurer of Hambrecht & Quist Capital Mgmt LLC (Age 62)
- Ms. Laura F. Woodward, Chief Compliance Officer, Treasurer and Sec. (Age 50)
- Dr. Jason C. Akus M.D., MBA, VP of Research and Portfolio Mang.
- Mr. Christopher F. Brinzey, Sr. VP of Research and Portfolio Mang.
Who are Tekla Healthcare Investors' major shareholders?
Tekla Healthcare Investors' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Boston Advisors LLC (0.22%) and Steward Partners Investment Advisory LLC (0.05%). Company insiders that own Tekla Healthcare Investors stock include Daniel R Omstead and Thomas M Kent. View Institutional Ownership Trends for Tekla Healthcare Investors.
Which institutional investors are buying Tekla Healthcare Investors stock?
HQH stock was bought by a variety of institutional investors in the last quarter, including Boston Advisors LLC and Steward Partners Investment Advisory LLC. Company insiders that have bought Tekla Healthcare Investors stock in the last two years include Daniel R Omstead and Thomas M Kent. View Insider Buying and Selling for Tekla Healthcare Investors.
How do I buy shares of Tekla Healthcare Investors?
Shares of HQH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tekla Healthcare Investors' stock price today?
One share of HQH stock can currently be purchased for approximately $20.71.
How big of a company is Tekla Healthcare Investors?
Tekla Healthcare Investors has a market capitalization of $853.72 million.
What is Tekla Healthcare Investors' official website?
How can I contact Tekla Healthcare Investors?
Tekla Healthcare Investors' mailing address is 2 LIBERTY SQUARE 9TH FLOOR, BOSTON MA, 02109. The financial services provider can be reached via phone at 617-772-8500 or via email at [email protected]
MarketBeat Community Rating for Tekla Healthcare Investors (NYSE HQH)
MarketBeat's community ratings are surveys of what our community members think about Tekla Healthcare Investors and other stocks. Vote "Outperform" if you believe HQH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQH will underperform the S&P 500 over the long term. You may vote once every thirty days.
